Chapter 24 Neuromuscular Disorders

Question 0

Generalized muscular weakness of patient with MG

Answer 0

Myasthenic crisis

Question 1

MG patients have inadequate secretion of this neurotransmitter

Answer 1

Acetylcholine

Question 2

Drug used to diagnose MG

Answer 2

Edrophonium

Question 3

Involuntary muscle twitching

Answer 3

Fasciculations

Question 4

First acetylcholinesterase inhibitor used to control MG

Answer 4

Neostigmine

Question 5

Abnormal pupil constriction

Answer 5

Mitosis

Question 6

MS forms plaques on this area of the nerve

Answer 6

Myelin sheath

Question 7

A direct acting drug that is effective in reducing spasticity in patients with MS

Answer 7

Dantrium

Question 8

Drooling, excessive tearing, sweating and mitosis are signs of

Cholinergic crisis
Myasthenic crisis

Answer 8

Cholinergic crisis

Question 9

Emergency med given to patient exhibiting signs of cholinergic crisis
Valium
Tension
Atropine

Answer 9

Atropine

Question 10

If provider considering diagnosis of MS what test will he likely order

Answer 10

MRI

Question 11

When patient is receiving mestinon there is increased toxicity if this drug is taken

Answer 11

Tetracycline

Question 12

Imuran and betaseron are biologic response modifiers and immunosuppressants. They are used to decrease or increase inflammatory process of the nerve fibers

Answer 12

Decrease

They reduce spasticity and improve muscular movement

Question 13

How do centrally acting muscle relaxants improve MS

Answer 13

Decrease pain

Increase ROM

Question 14

Side effects of Robaxin

Answer 14

Brown urine

Drowsiness

Question 15

Contraindication of Diazapam

Answer 15

Narrow angle glaucoma

Question 16

Central acting muscle relaxant

Utilized for muscle spasms

Answer 16

Carisoprodol (Soma)

Question 17

Used specifically for spasticity either due to trauma or MS

Answer 17

Baclofen

Question 18

Side effects of carisoprodol and baclofen

Answer 18

Drowsiness
Dizziness
Nausea
Hypotension
Baclofen does not have abuse potential 
Carisoprodol is a schedule IV